Literature DB >> 24106131

Chemical and structural insights into the regioversatility of the aminoglycoside acetyltransferase Eis.

Jacob L Houghton1, Tapan Biswas, Wenjing Chen, Oleg V Tsodikov, Sylvie Garneau-Tsodikova.   

Abstract

A recently discovered cause of tuberculosis resistance to a drug of last resort, the aminoglycoside kanamycin, results from modification of this drug by the enhanced intracellular survival (Eis) protein. Eis is a structurally and functionally unique acetyltransferase with an unusual capability of acetylating aminoglycosides at multiple positions. The extent of this regioversatility and its defining protein features are unclear. Herein, we determined the positions and order of acetylation of five aminoglycosides by NMR spectroscopy. This analysis revealed unprecedented acetylation of the 3''-amine of kanamycin, amikacin, and tobramycin, and the γ-amine of the 4-amino-2-hydroxybutyryl group of amikacin. A crystal structure of Eis in complex with coenzyme A and tobramycin revealed how tobramycin can be accommodated in the Eis active site in two binding modes, consistent with its diacetylation. These studies, describing chemical and structural details of acetylation, will guide future efforts towards designing aminoglycosides and Eis inhibitors to overcome resistance in tuberculosis.
Copyright © 2013 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  bacterial resistance; enhanced intracellular survival protein; enzymatic reaction; multi-acetylation; tuberculosis

Mesh:

Substances:

Year:  2013        PMID: 24106131      PMCID: PMC3947475          DOI: 10.1002/cbic.201300359

Source DB:  PubMed          Journal:  Chembiochem        ISSN: 1439-4227            Impact factor:   3.164


  27 in total

1.  Novel arbekacin- and amikacin-modifying enzyme of methicillin-resistant Staphylococcus aureus.

Authors:  S Fujimura; Y Tokue; H Takahashi; T Kobayashi; K Gomi; T Abe; T Nukiwa; A Watanabe
Journal:  FEMS Microbiol Lett       Date:  2000-09-15       Impact factor: 2.742

2.  Novel computer program for fast exact calculation of accessible and molecular surface areas and average surface curvature.

Authors:  Oleg V Tsodikov; M Thomas Record; Yuri V Sergeev
Journal:  J Comput Chem       Date:  2002-04-30       Impact factor: 3.376

3.  Aminoglycoside multiacetylating activity of the enhanced intracellular survival protein from Mycobacterium smegmatis and its inhibition.

Authors:  Wenjing Chen; Keith D Green; Oleg V Tsodikov; Sylvie Garneau-Tsodikova
Journal:  Biochemistry       Date:  2012-06-05       Impact factor: 3.162

4.  Overexpression of the chromosomally encoded aminoglycoside acetyltransferase eis confers kanamycin resistance in Mycobacterium tuberculosis.

Authors:  M Analise Zaunbrecher; R David Sikes; Beverly Metchock; Thomas M Shinnick; James E Posey
Journal:  Proc Natl Acad Sci U S A       Date:  2009-11-11       Impact factor: 11.205

5.  Unexpected N-acetylation of capreomycin by mycobacterial Eis enzymes.

Authors:  Jacob L Houghton; Keith D Green; Rachel E Pricer; Abdelrahman S Mayhoub; Sylvie Garneau-Tsodikova
Journal:  J Antimicrob Chemother       Date:  2012-12-11       Impact factor: 5.790

6.  Mycobacterium tuberculosis Eis protein initiates suppression of host immune responses by acetylation of DUSP16/MKP-7.

Authors:  Kyoung Hoon Kim; Doo Ri An; Jinsu Song; Ji Young Yoon; Hyoun Sook Kim; Hye Jin Yoon; Ha Na Im; Jieun Kim; Do Jin Kim; Sang Jae Lee; Ki-Hye Kim; Hye-Mi Lee; Hie-Joon Kim; Eun-Kyeong Jo; Jae Young Lee; Se Won Suh
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-30       Impact factor: 11.205

7.  Molecular genetics of Mycobacterium tuberculosis resistant to aminoglycosides and cyclic peptide capreomycin antibiotics in Korea.

Authors:  Hum Nath Jnawali; Heekyung Yoo; Sungweon Ryoo; Kwang-Jun Lee; Bum-Joon Kim; Won-Jung Koh; Chang-Ki Kim; Hee-Jin Kim; Young Kil Park
Journal:  World J Microbiol Biotechnol       Date:  2013-01-18       Impact factor: 3.312

8.  Biochemical and structural analysis of aminoglycoside acetyltransferase Eis from Anabaena variabilis.

Authors:  Rachel E Pricer; Jacob L Houghton; Keith D Green; Abdelrahman S Mayhoub; Sylvie Garneau-Tsodikova
Journal:  Mol Biosyst       Date:  2012-10-30

9.  Crystal structure of a complex between the aminoglycoside tobramycin and an oligonucleotide containing the ribosomal decoding a site.

Authors:  Quentin Vicens; Eric Westhof
Journal:  Chem Biol       Date:  2002-06

10.  Phaser crystallographic software.

Authors:  Airlie J McCoy; Ralf W Grosse-Kunstleve; Paul D Adams; Martyn D Winn; Laurent C Storoni; Randy J Read
Journal:  J Appl Crystallogr       Date:  2007-07-13       Impact factor: 3.304

View more
  33 in total

1.  Combating Enhanced Intracellular Survival (Eis)-Mediated Kanamycin Resistance of Mycobacterium tuberculosis by Novel Pyrrolo[1,5-a]pyrazine-Based Eis Inhibitors.

Authors:  Atefeh Garzan; Melisa J Willby; Huy X Ngo; Chathurada S Gajadeera; Keith D Green; Selina Y L Holbrook; Caixia Hou; James E Posey; Oleg V Tsodikov; Sylvie Garneau-Tsodikova
Journal:  ACS Infect Dis       Date:  2017-02-17       Impact factor: 5.084

2.  Antimicrobial Activity, AME Resistance, and A-Site Binding Studies of Anthraquinone-Neomycin Conjugates.

Authors:  Natalya N Degtyareva; Changjun Gong; Sandra Story; Nathanael S Levinson; Adegboyega K Oyelere; Keith D Green; Sylvie Garneau-Tsodikova; Dev P Arya
Journal:  ACS Infect Dis       Date:  2017-02-17       Impact factor: 5.084

3.  Amphiphilic Tobramycin Analogues as Antibacterial and Antifungal Agents.

Authors:  Sanjib K Shrestha; Marina Y Fosso; Keith D Green; Sylvie Garneau-Tsodikova
Journal:  Antimicrob Agents Chemother       Date:  2015-06-01       Impact factor: 5.191

4.  Tobramycin Variants with Enhanced Ribosome-Targeting Activity.

Authors:  Marina Y Fosso; Hongkun Zhu; Keith D Green; Sylvie Garneau-Tsodikova; Kurt Fredrick
Journal:  Chembiochem       Date:  2015-06-17       Impact factor: 3.164

5.  New trends in aminoglycosides use.

Authors:  Marina Y Fosso; Yijia Li; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2014-08-01       Impact factor: 3.597

6.  A review of patents (2011-2015) towards combating resistance to and toxicity of aminoglycosides.

Authors:  Nishad Thamban Chandrika; Sylvie Garneau-Tsodikova
Journal:  Medchemcomm       Date:  2015-11-19       Impact factor: 3.597

7.  Potent Inhibitors of Acetyltransferase Eis Overcome Kanamycin Resistance in Mycobacterium tuberculosis.

Authors:  Melisa J Willby; Keith D Green; Chathurada S Gajadeera; Caixia Hou; Oleg V Tsodikov; James E Posey; Sylvie Garneau-Tsodikova
Journal:  ACS Chem Biol       Date:  2016-04-07       Impact factor: 5.100

8.  Expanding Aminoglycoside Resistance Enzyme Regiospecificity by Mutation and Truncation.

Authors:  Selina Y L Holbrook; Sylvie Garneau-Tsodikova
Journal:  Biochemistry       Date:  2016-09-26       Impact factor: 3.162

9.  Comparative Study of Eis-like Enzymes from Pathogenic and Nonpathogenic Bacteria.

Authors:  Keith D Green; Rachel E Pricer; Megan N Stewart; Sylvie Garneau-Tsodikova
Journal:  ACS Infect Dis       Date:  2015-05-04       Impact factor: 5.084

10.  Synthesis and Biological Activity of Mono- and Di-N-acylated Aminoglycosides.

Authors:  Nishad Thamban Chandrika; Keith D Green; Jacob L Houghton; Sylvie Garneau-Tsodikova
Journal:  ACS Med Chem Lett       Date:  2015-09-30       Impact factor: 4.345

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.